The NIH Scandal and the Future of AIDS Research (tags)
Why isn’t the NIH interested in competitive AIDS research? That’s the billion-dollar question. That is, if inexpensive micronutrients and competitive disease and treatment models prove more successful than the current research, it will represent a loss of billions for the AIDS drug and research industry.
“I have a large population of people who have chosen not to take any anti-retrovirals. They’ve watched all of their friends go on the anti-viral bandwagon and die.” – Dr. Donald Abrams, MD, Director of AIDS Program, San Francisco General Hospital (“Lecture to Medical Students,” Synapse, 1996)